Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 April 2025 | Story Onthatile Tikoe | Photo Onthatile Tikoe
Zane Dippenaar
Dr Zané Dippenaar (30) is the youngest PhD graduate in this year’s Business Management class from the University of the Free State.

Zané Dippenaar, a 30-year-old marketing and project manager at a Cape Town-based solar energy company, is the youngest person in this year’s graduating class to earn a Doctor of Philosophy (PhD) in Business Management degree from the University of the Free State this year.  

But despite this achievement, the newly minted Dr Dippenaar says she would not have predicted she would study her way to PhD level. 

“I wasn’t particularly academically driven before tertiary education, but I knew from early on that I wanted to either become a teacher or pursue something in the world of business,” she says. Her natural ability and her family’s encouragement led her to explore entrepreneurship and marketing, which she soon developed a passion for.

 

Overcoming challenges and finding support

Dr Dippenaar’s academic journey was marked by significant challenges, including balancing work and study commitments. However, she credits her supervisors and family for helping her stay motivated. 

Her dissertation, titled ‘Advertising and Brand Loyalty in the South African Solar Industry’, showcases her expertise in marketing and branding.

“There were moments filled with doubt, setbacks, and exhaustion, but I was fortunate to have a strong support system who continuously encouraged me and reminded me of what I was working towards,” she says.

 

Achieving a personal milestone

Dr Dippenaar’s PhD achievement is not only an academic milestone but also a personal triumph. She had set a goal of completing her PhD before turning 30 and achieved it just weeks before her birthday. “That was a personal milestone I had set for myself, and achieving it was incredibly fulfilling,” she says. 

She plans to apply the knowledge she gained in the industry and potentially return to academia. She advises younger students to trust their instincts and start their academic journey without waiting for perfection.

“Don’t wait until you’re ‘ready’ – you never will be. Just start. Surround yourself with people who believe in you, ask for help when you need it, and take it one chapter at a time,” she advises.

 

A role model for others

Dr Dippenaar hopes to inspire others, particularly young women, by showing that success in academia doesn’t follow a one-size-fits-all formula. “I hope my story demonstrates that with the right support, determination, and a willingness to carve your own path, anything is possible.”

The University of the Free State is proud to have played a role in Dippenaar’s academic journey, fostering her growth and expertise in business management. Her achievement is a testament to the institution’s commitment to academic excellence and innovation.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept